Reversal of Gangrenous Lesions in the Blue Toe Syndrome with Lovastatin A Case Report
- 1 October 1993
- journal article
- case report
- Published by SAGE Publications in Angiology
- Vol. 44 (10) , 821-825
- https://doi.org/10.1177/000331979304401010
Abstract
A seventy-six-year-old man with ischemic heart disease, peripheral vascular disease, and chronic renal failure developed bilateral cyanotic toes, which upon muscle biopsy, were shown to be caused by atheromatous emboli. The probable source was atheromatosis of the abdominal aorta. The toes became gangrenous, but surgical therapy was deferred because the patient was considered a high risk. With lovastatin therapy there was complete healing and except for transient cyanosis related to temporary cessation of therapy, there has been no recurrence for the past thirty months. The possible role of lovastatin in the conservative treatment of this disorder is discussed.Keywords
This publication has 19 references indexed in Scilit:
- Management of Multiple Cholesterol Embolization Syndrome-A Case ReportAngiology, 1990
- Cholesterol Emboli After Cardiac CatheterizationMedicine, 1988
- Cholesterol Embolization SyndromePublished by American Medical Association (AMA) ,1987
- Cholesterol Crystal Embolization: A Review of 221 Cases in the English LiteratureAngiology, 1987
- The relationship between carotid plaque composition and neurologic symptomsJournal of Surgical Research, 1987
- Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases.Heart, 1984
- Blue digit syndrome: urgent indication for digital salvageThe American Journal of Surgery, 1984
- Gangrene of the Toes with Palpable Peripheral Pulses. Response to Platelet Suppressive TherapyAnnals of Surgery, 1981
- Control of cholesterol embolization by discontinuation of anticoagulant therapyThe Lancet Healthy Longevity, 1978
- "Blue Toe" SyndromeArchives of Surgery, 1976